Hims & Hers (NYSE: HIMS) director reports sale of 2,500 shares at $39.17
Rhea-AI Filing Summary
Hims & Hers Health, Inc. director Andrea G. Perez Garcia reported a stock sale in a Form 4 filing. On 12/09/2025, the reporting person sold 2,500 shares of Class A common stock of Hims & Hers Health, Inc. at a price of $39.17 per share, in a transaction coded "S" for sale.
After this transaction, the reporting person beneficially owns 80,166 shares of Hims & Hers Health, Inc. Class A common stock in direct ownership. The filing notes that it was submitted as a Form 4 for one reporting person who serves as a director of the company.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did HIMS disclose in this Form 4?
The filing reports that a director of Hims & Hers Health, Inc. (HIMS), Andrea G. Perez Garcia, sold 2,500 shares of Class A common stock on 12/09/2025.
At what price were the HIMS shares sold in this insider transaction?
The 2,500 shares of Hims & Hers Health, Inc. Class A common stock were sold at a price of $39.17 per share.
How many HIMS shares does the reporting person own after the sale?
Following the reported sale, the director beneficially owns 80,166 shares of Hims & Hers Health, Inc. Class A common stock in direct ownership.
What is the relationship of the reporting person to Hims & Hers Health, Inc.?
The reporting person, Andrea G. Perez Garcia, is identified as a director of Hims & Hers Health, Inc. in the filing.
Does this HIMS Form 4 include any derivative securities transactions?
The section for derivative securities is present, but no derivative securities acquisitions or dispositions are listed in the provided table.
Was this HIMS Form 4 filed jointly by multiple reporting persons?
No. The form indicates that it was filed by one reporting person, not by more than one reporting person.